Nortis Home                 Page


  • July 2014: MedCity News publishes article on approaching commercial launch (
  • June 2014: Nortis receives multimillion dollar Series A funding to support commercial launch.
  • June 20, 2014: Nortis introduces its technology at Life Science Innovation Northwest.
  • January 2014: Nortis is awarded pilot study funding from the PATH Malaria Vaccine Initiative (MVI).
  • September 2013: Nortis is awarded NIH/NCI, SBIR contract for developing a brain metastasis assay for drug screening.
  • August 2013: Nortis is awarded funding by the PATH Malaria Vaccine Initiative (MVI) to develop a platform for testing transmission blocking vaccines.
  • November 2012: Nortis is awarded a grant from the Bill & Melinda Gates Foundation to develop a chip for testing anti-malaria drugs.



Nortis               Index
Technology Applications About Us Contact Us Home Page